Ocuphire Pharma (OCUP) Short Interest Ratio & Short Volume → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free OCUP Stock Alerts $1.69 -0.02 (-1.17%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ocuphire Pharma Short Interest DataCurrent Short Interest1,320,000 sharesPrevious Short Interest1,220,000 sharesChange Vs. Previous Month+8.20%Dollar Volume Sold Short$2.28 millionShort Interest Ratio6.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares25,924,000 sharesPercentage of Shares Shorted5.09%Today's Trading Volume75,348 sharesAverage Trading Volume121,373 sharesToday's Volume Vs. Average62% Short Selling Ocuphire Pharma ? Sign up to receive the latest short interest report for Ocuphire Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOCUP Short Interest Over TimeOCUP Days to Cover Over TimeOCUP Percentage of Float Shorted Over Time Ad Market Moving TrendsTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Click to View The 5 Best AI Stocks to Invest In Ocuphire Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,320,000 shares $2.28 million +8.2%N/A6 $1.73 4/30/20241,220,000 shares $1.93 million -22.8%N/A5.3 $1.59 4/15/20241,580,000 shares $2.78 million +0.6%N/A7.1 $1.76 3/31/20241,570,000 shares $3.16 million -4.9%N/A7.1 $2.01 3/15/20241,650,000 shares $3.14 million -2.4%N/A7.8 $1.90 2/29/20241,690,000 shares $4.29 million -3.4%N/A7.9 $2.54 Get the Latest News and Ratings for OCUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,750,000 shares $4.64 million +1.2%N/A8.1 $2.65 1/31/20241,730,000 shares $4.53 million +4.2%N/A7.6 $2.62 1/15/20241,660,000 shares $4.98 million +5.1%N/A7.6 $3.00 12/31/20231,580,000 shares $4.76 million -9.7%N/A7.3 $3.01 12/15/20231,750,000 shares $4.60 million -0.6%N/A6.2 $2.63 11/30/20231,760,000 shares $5.37 million +3.5%N/A6.4 $3.05 11/15/20231,700,000 shares $5.36 million -2.3%N/A6.5 $3.15 10/31/20231,740,000 shares $4.96 million -7.5%N/A7.1 $2.85 10/15/20231,880,000 shares $6.28 million +3.9%N/A8.2 $3.34 9/30/20231,810,000 shares $6.06 million +27.5%N/A8.1 $3.35 9/15/20231,420,000 shares $5.69 million -2.7%N/A8.2 $4.01 8/31/20231,460,000 shares $5.83 million -8.2%N/A10.2 $3.99 8/15/20231,590,000 shares $6.66 million -1.2%N/A9.5 $4.19 7/31/20231,610,000 shares $6.97 million -1.2%N/A6.8 $4.33 7/15/20231,630,000 shares $6.75 million +5.2%N/A5.1 $4.14 6/30/20231,550,000 shares $6.73 million +5.4%N/A4.2 $4.34 6/15/20231,470,000 shares $5.87 million -4.6%N/A3.8 $3.99 5/31/20231,540,000 shares $5.94 million -24.5%N/A4.1 $3.86 5/15/20232,040,000 shares $10.24 million +11.5%N/A6 $5.02 4/30/20231,830,000 shares $9.39 million +45.2%N/A6.9 $5.13 4/15/20231,260,000 shares $6.75 million +86.7%N/A5.2 $5.36 3/31/2023675,000 shares $2.53 million -25.5%N/A4.2 $3.75 3/15/2023906,400 shares $3.40 million +0.2%N/A7.2 $3.75 2/28/2023904,800 shares $3.12 million -3.4%N/A7 $3.45 2/15/2023936,500 shares $3.59 million -5.8%N/A6.8 $3.83 1/31/2023994,000 shares $3.45 million -7.1%N/A3.7 $3.47 1/15/20231,070,000 shares $3.94 million +5.9%N/A4.4 $3.68 12/30/20221,010,000 shares $3.57 million -3.8%N/A4.3 $3.53 12/15/20221,050,000 shares $3.10 million -1.9%N/A5 $2.95 11/30/20221,070,000 shares $3.30 million -5.3%N/A5.2 $3.08 11/15/20221,130,000 shares $3.22 million +220.3%N/A5.7 $2.85 10/31/2022352,800 shares $829,080.00 +16.5%N/A2 $2.35 10/15/2022302,800 shares $663,132.00 -25.1%N/A3.9 $2.19 9/30/2022404,300 shares $812,643.00 -12.0%N/A5.3 $2.01Breaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here. 9/15/2022459,400 shares $1.06 million -0.4%N/A5.4 $2.30 8/31/2022461,400 shares $1.05 million -16.9%N/A5.1 $2.27 8/15/2022555,500 shares $1.40 million +104.9%N/A5.6 $2.52 7/31/2022271,100 shares $506,957.00 +4.6%N/A2.5 $1.87 7/15/2022259,200 shares $495,072.00 -4.4%N/A2.3 $1.91 6/30/2022271,200 shares $520,704.00 -11.6%N/A2.1 $1.92 6/15/2022306,800 shares $564,512.00 -22.7%N/A1.6 $1.84 5/31/2022397,100 shares $841,852.00 +28.8%N/A1.9 $2.12 5/15/2022308,300 shares $662,845.00 +3.4%N/A1.5 $2.15 4/30/2022298,200 shares $697,788.00 -1.3%N/A1.6 $2.34 4/15/2022302,100 shares $845,880.00 +2.9%N/A1.5 $2.80 3/31/2022293,600 shares $951,264.00 +77.0%N/A1.4 $3.24 3/15/2022165,900 shares $552,447.00 +18.5%N/A0.9 $3.33 2/28/2022140,000 shares $478,800.00 -2.5%N/A0.6 $3.42 2/15/2022143,600 shares $488,240.00 -18.3%N/A0.1 $3.40 1/31/2022175,800 shares $557,286.00 -35.8%N/A0.1 $3.17 1/15/2022273,700 shares $1.01 million -44.8%N/A0.2 $3.69 12/31/2021495,700 shares $1.85 million -42.9%N/A0.3 $3.73 12/15/2021868,600 shares $3.33 million -64.7%N/A0.5 $3.83 11/30/20212,460,000 shares $9.62 million +550.6%N/A1.4 $3.91 11/15/2021378,100 shares $1.49 million -15.1%N/A0.2 $3.95 10/29/2021445,400 shares $1.75 million -27.0%N/A2.1 $3.94 10/15/2021610,200 shares $2.62 million -19.7%N/A2 $4.29 9/30/2021760,200 shares $3.92 million +29.9%N/A2.2 $5.15 9/15/2021585,300 shares $2.87 million -29.4%N/A0.4 $4.91 8/31/2021828,500 shares $3.69 million -31.0%N/A0.6 $4.45 8/13/20211,200,000 shares $5.46 million -23.6%N/A0.8 $4.55 7/30/20211,570,000 shares $6.59 million -17.4%N/A1 $4.20 7/15/20211,900,000 shares $7.54 million +311.3%N/A1.3 $3.97 6/30/2021461,900 shares $2.44 million -20.2%N/A0.3 $5.28 6/15/2021578,600 shares $3.04 million +8.9%5.6%1.2 $5.25 5/28/2021531,100 shares $2.41 million -12.0%4.9%1 $4.54 5/14/2021603,600 shares $2.67 million -2.5%5.7%1.3 $4.43 4/30/2021619,000 shares $3.16 million +85.8%5.9%1.5 $5.11 4/15/2021333,200 shares $1.64 million +118.8%3.6%0.9 $4.91 3/31/2021152,300 shares $868,110.00 +2,045.1%1.7%0.4 $5.70 3/15/20217,100 shares $56,445.00 -60.6%0.1%0 $7.95 2/26/202118,000 shares $191,520.00 +125.0%0.2%0.2 $10.64 2/12/20218,000 shares $97,040.00 -67.6%0.1%0.1 $12.13 1/29/202124,700 shares $295,041.50 +107.6%0.2%0.3 $11.95 1/15/202111,900 shares $82,824.00 No Change0.1%0.2 $6.96 OCUP Short Interest - Frequently Asked Questions What is Ocuphire Pharma's current short interest? Short interest is the volume of Ocuphire Pharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 1,320,000 shares of OCUP short. Learn More on Ocuphire Pharma's current short interest. What is a good short interest ratio for Ocuphire Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUP shares currently have a short interest ratio of 6.0. Learn More on Ocuphire Pharma's short interest ratio. Which institutional investors are shorting Ocuphire Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocuphire Pharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Ocuphire Pharma's short interest increasing or decreasing? Ocuphire Pharma saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,320,000 shares, an increase of 8.2% from the previous total of 1,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocuphire Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ocuphire Pharma: Rigel Pharmaceuticals, Inc. (3.22%), Galectin Therapeutics Inc. (8.75%), Atossa Therapeutics, Inc. (9.13%), Lifecore Biomedical, Inc. (6.86%), G1 Therapeutics, Inc. (6.87%), Alimera Sciences, Inc. (0.20%), ProQR Therapeutics (0.45%), Seres Therapeutics, Inc. (15.01%), Werewolf Therapeutics, Inc. (1.25%), Sagimet Biosciences Inc. (10.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Ocuphire Pharma stock? Short selling OCUP is an investing strategy that aims to generate trading profit from Ocuphire Pharma as its price is falling. OCUP shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocuphire Pharma? A short squeeze for Ocuphire Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUP, which in turn drives the price of the stock up even further. How often is Ocuphire Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUP, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RIGL Short Squeeze GALT Short Squeeze ATOS Short Squeeze LFCR Short Squeeze GTHX Short Squeeze ALIM Short Squeeze PRQR Short Squeeze MCRB Short Squeeze HOWL Short Squeeze SGMT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUP) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocuphire Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.